Impact of RSV hospitalization on healthcare costs, caregivers' productivity loss, and quality of life in children ≤ 2 years old in five European countries.

Saved in:
Bibliographic Details
Title: Impact of RSV hospitalization on healthcare costs, caregivers' productivity loss, and quality of life in children ≤ 2 years old in five European countries.
Authors: Wildenbeest JG; Department of Paediatric Infectious Diseases and Immunology, Wilhelmina Children's Hospital, University Medical Center Utrecht, KC.03.063.0, P.O. Box 85090, 3508 AB, Utrecht, the Netherlands. j.g.wildenbeest@umcutrecht.nl., Bont L; Department of Paediatric Infectious Diseases and Immunology, Wilhelmina Children's Hospital, University Medical Center Utrecht, KC.03.063.0, P.O. Box 85090, 3508 AB, Utrecht, the Netherlands., Cianci D; Julius Center for Health Sciences and Primary Care, Department of Data Science & Biostatistics, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Frederix GWJ; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands., Calvo C; Hospital Universitario La Paz, IdiPaz Foundation, CIBERINFEC, Universidad Autónoma de Madrid, Madrid, Spain., Liese J; Department of Paediatrics, University Hospital Würzburg, Würzburg, Germany., Cutrera R; Pneumology and Cystic Fibrosis Unit, Bambino Gesù' Children's Hospital, IRCCS, Rome, Italy., Azzari C; Department of Health Sciences, University of Florence, Florence, Italy.; Immunology Unit, Department of Pediatrics, Meyer Children's Hospital IRCCS, Florence, Italy., Brouard J; INSERM U1311, Dynamicure, UNICAEN, UNIROUEN, Department of Medical Pediatrics, University Hospital Center of Caen, Caen, France., Martinon-Torres F; Translational Paediatrics and Infectious Diseases Section, Paediatrics Department, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, Spain.; Genetics, Vaccines, and Infections Research Group (GENVIP), Healthcare Research Institute of Santiago de Compostela, University of Santiago de Compostela, Santiago de Compostela, Spain.; CIBER of Respiratory Diseases (CIBERES), Instituto de Salud Carlos III, Madrid, Spain., Herting E; University Hospital Schleswig Holstein - Campus Lübeck, Lübeck, Germany., Drysdale SB; St. George's University Hospital NHS Foundation Trust, London, United Kingdom., Epaud R; Paediatric Department, Centre Hospitalier Intercommunal de Créteil, Reference Centre for Rare Lung Diseases (RespiRare®), University Paris Est Créteil, INSERM, IMRB, Créteil, France., Gupta A; Paediatric Respiratory Department, King's College Hospital, London, United Kingdom.; Paediatric Respiratory Department, Faculty of Life Sciences and Medicine, King's College London, London, United Kingdom., Ruggieri M; Value and Implementation Outcomes Research, Merck & Co., Inc., Rahway, NJ, USA., Choi Y; Value and Implementation Outcomes Research, Merck & Co., Inc., Rahway, NJ, USA.
Corporate Authors: BRICE Study Group
Source: European journal of pediatrics [Eur J Pediatr] 2025 Oct 25; Vol. 184 (11), pp. 716. Date of Electronic Publication: 2025 Oct 25.
Publication Type: Clinical Study; Journal Article; Multicenter Study
Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7603873 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-1076 (Electronic) Linking ISSN: 03406199 NLM ISO Abbreviation: Eur J Pediatr Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1432-1076
DOI:10.1007/s00431-025-06460-7